Nomura Holdings
AGIO icon

Nomura Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Nomura Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,000
Closed -$1.25M – 1510
2024
Q2 		$1.25M Buy
+29,000
New +$1.05M ﹤0.01% 1081

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Nomura Holdings's AGIO Position: Q1 2026 in Review

Nomura Holdings reduced its Agios Pharmaceuticals (AGIO) stake by 26% in Q1 2026, selling an estimated $90.1K and leaving 9,176 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Nomura Holdings first reported a position in AGIO in Q3 2013 and has held it in 8 quarters since. The position peaked at $522K in Q2 2024. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Nomura Holdings held 9,176 shares of Agios Pharmaceuticals worth $310K as of Q1 2026.
  • Nomura Holdings sold 3,179 Agios Pharmaceuticals shares in Q1 2026, an estimated $90.1K.
  • Agios Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1485 holding.
  • Nomura Holdings first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 8 quarters since.
  • Nomura Holdings's Agios Pharmaceuticals position peaked at $522K in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.